New Opportunities for Oral Sustained Release Formulations with Polyvinyl Alcohol

This white paper describes the use of PVA-based Parteck® SRP 80, a functional excipient specifically developed for matrix-based sustained release oral solid dose formulations. With a mean particle size of 80 µm, Parteck® SRP 80 excipient is a PVA optimized for drug dissolution, easy handling, good flowability and good reproducibility with respect to both sustained API release and direct compression (DC) manufacturability. Batch-to-batch consistency ensures consistent quality and enables use of QbD to further minimize risks in development and manufacture. Parteck® SRP 80 excipient is also compliant with Ph. Eur., USP, ChP and JPE monographs.

Download the Document

    * denotes a required field
    Please fill out the information below to request information for the products you selected. If you are already registered, or have requested a quote before, and this information will be filled out for you.
  • Please enter your first and last name.

  • Please enter the name of the company or institution you work at.

  • Please enter your mailing address.

  • Please enter the phone number you would like to be contacted at.

  • Please enter the e-mail address you would like to be contacted at.